Saturday, 14 April 2012

Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial

The aim of this preliminary study was to evaluate the effect of low-dose oral vitamin D in combination with current disease-modifying therapy on the prevention of progression of relapsing-remitting multiple sclerosis (RRMS). A phase II double-blind placebo-controlled randomized clinical trial conducted between October 2007 and October 2008 included 50 patients with confirmed RRMS aged 25 to 57 years and normal serum 25-hydroxyvitamin D. They were randomly allocated to receive 12 months of treatment with either escalating calcitriol doses up to 0.5 μg/day or placebo combined with disease-modifying therapy. Response to treatment was assessed at eight-week intervals. In both groups, the mean relapse rate decreased significantly (P<0.001). In the 25 patients treated with ...

Source: http://www.medworm.com/index.php?rid=5883560&cid=u_0_29_f&fid=37029&url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fmsi%2F2012%2F452541%2F

phlebotomy certification nj phlebotomist training in nyc phlebotomy certification in virginia

No comments:

Post a Comment